Cellectis S.A Return on Equity (ROE) Growth & History (CLLS)

Cellectis S.A's return on equity was −65.33% for fiscal 2025.

View full Cellectis S.A company overview

Cellectis S.A annual return on equity history

Cellectis S.A annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−65.33%−31.25 pp
20242024-12-31−34.08%+72.94 pp
20232023-12-31−107.02%−39.79 pp
20222022-12-31−67.22%−17.69 pp
20212021-12-31−49.54%−16.99 pp
20202020-12-31−32.55%−0.75 pp
20192019-12-31−31.81%−5.60 pp
20182018-12-31−26.20%+12.36 pp
20172017-12-31−38.57%−14.51 pp
20162016-12-31−24.06%−11.50 pp
20152015-12-31−12.56%

Cellectis S.A return on equity trends

Over the last five fiscal years, Cellectis S.A's return on equity decreased from −32.55% to −65.33%, a change of −32.78 percentage points. The latest reported quarter, Q2 2026, shows −43.21%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cellectis S.A source filings ↗

Community posts

It’s quiet here.

No posts about CLLS yet. Start the conversation.

Write the first post